OmniAb, Inc. (OABI) vs Solid Biosciences Inc. (SLDB)
A side-by-side comparison of OmniAb, Inc. and Solid Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
OABI
OmniAb, Inc.
$4.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SLDB
Solid Biosciences Inc.
$6.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — OABI vs SLDB
growth of $100 · dividends reinvested · last 5yOABI -49.6% (-12.8%/yr)SLDB -80.8% (-28.1%/yr)OABI compounded faster over this window
OABI SLDB
OABI vs SLDB: by the numbers
- •SLDB is the larger company ($681M vs $631M market cap).
- •Both run net losses; SLDB's is the smaller (0.00% vs -115.18% net margin).
Metrics side by side
Valuation
| Metric | OABI | SLDB |
|---|---|---|
| P/S ratio | 16.41 | N/A |
| P/B ratio | 2.42 | 1.82 |
Profitability
| Metric | OABI | SLDB |
|---|---|---|
| Gross margin | -18.17% | 0.00% |
| Operating margin | -383.15% | 0.00% |
| Net margin | -115.18% | 0.00% |
| ROE | -17.01% | -55.36% |
| ROIC | -17.48% | -54.12% |
Growth (annualized)
| Metric | OABI | SLDB |
|---|---|---|
| Revenue CAGR (5Y) | -4.31% | N/A |
| Total return CAGR (5Y) | -13.17% | -27.50% |
Frequently asked
- How have OABI and SLDB total returns compared?
- Over the past 5 years, OABI delivered -13.17% and SLDB delivered -27.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.